Literature DB >> 28432635

Role of Inflammation in Heart Failure.

Lily F Shirazi1, Joe Bissett1, Francesco Romeo1,2, Jawahar L Mehta3.   

Abstract

PURPOSE OF REVIEW: This paper aims to discuss the interactions between inflammatory cytokines, immune cells, and heart failure (HF). The association of heart failure with inflammation has led to multiple studies on anti-inflammatory agents in acute and chronic heart failure. RECENT
FINDINGS: Recent findings have implicated leukocytes subclasses and multiple inflammatory mediators in the progression of heart failure and cardiovascular disease. Studies have discovered further details on the interaction between immune cells-particularly macrophages and lymphocytes-and inflammation. There are both cell-mediated and cytokine-mediated pathways of inflammation, which are interconnected. Additionally, a number of markers have been used and studied in heart failure disease progression. In this review, we discuss inflammatory biomarkers and immune cell mediators involved in HF. We will focus on the correlations and role of these inflammatory mediators in the genesis of HF. We will also discuss the evidence on beneficial effects of anti-inflammatory agents in the setting of chronic HF.

Entities:  

Keywords:  Cytokines; Heart failure; Immune cells; Inflammation; Leukocytes; Mediators

Mesh:

Substances:

Year:  2017        PMID: 28432635     DOI: 10.1007/s11883-017-0660-3

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  56 in total

1.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

Authors:  B Levine; J Kalman; L Mayer; H M Fillit; M Packer
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

2.  Circulating interleukin-10: association with higher mortality in systolic heart failure patients with elevated tumor necrosis factor-alpha.

Authors:  Offer Amir; Ori Rogowski; Miriam David; Nitza Lahat; Rafael Wolff; Basil S Lewis
Journal:  Isr Med Assoc J       Date:  2010-03       Impact factor: 0.892

3.  Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy.

Authors:  G Christian Baldeviano; Jobert G Barin; Monica V Talor; Sachin Srinivasan; Djahida Bedja; Dongfeng Zheng; Kathleen Gabrielson; Yoichiro Iwakura; Noel R Rose; Daniela Cihakova
Journal:  Circ Res       Date:  2010-04-08       Impact factor: 17.367

4.  Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta.

Authors:  B J Pomerantz; L L Reznikov; A H Harken; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

5.  Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH.

Authors:  A Rogier van der Velde; Lars Gullestad; Thor Ueland; Pål Aukrust; Yu Guo; Aram Adourian; Pieter Muntendam; Dirk J van Veldhuisen; Rudolf A de Boer
Journal:  Circ Heart Fail       Date:  2013-02-08       Impact factor: 8.790

6.  Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

Authors:  Douglas L Mann; John J V McMurray; Milton Packer; Karl Swedberg; Jeffrey S Borer; Wilson S Colucci; Jacques Djian; Helmut Drexler; Arthur Feldman; Lars Kober; Henry Krum; Peter Liu; Markku Nieminen; Luigi Tavazzi; Dirk Jan van Veldhuisen; Anders Waldenstrom; Marshelle Warren; Arne Westheim; Faiez Zannad; Thomas Fleming
Journal:  Circulation       Date:  2004-03-15       Impact factor: 29.690

7.  Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study.

Authors:  Ramachandran S Vasan; Lisa M Sullivan; Ronenn Roubenoff; Charles A Dinarello; Tamara Harris; Emelia J Benjamin; Douglas B Sawyer; Daniel Levy; Peter W F Wilson; Ralph B D'Agostino
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

8.  Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy.

Authors:  K Sliwa; D Skudicky; G Candy; T Wisenbaugh; P Sareli
Journal:  Lancet       Date:  1998-04-11       Impact factor: 79.321

9.  The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.

Authors:  Daniel I Swerdlow; Michael V Holmes; Karoline B Kuchenbaecker; Jorgen E L Engmann; Tina Shah; Reecha Sofat; Yiran Guo; Christina Chung; Anne Peasey; Roman Pfister; Simon P Mooijaart; Helen A Ireland; Maarten Leusink; Claudia Langenberg; Ka Wah Li; Jutta Palmen; Philip Howard; Jackie A Cooper; Fotios Drenos; John Hardy; Michael A Nalls; Yun Rose Li; Gordon Lowe; Marlene Stewart; Suzette J Bielinski; Julian Peto; Nicholas J Timpson; John Gallacher; Malcolm Dunlop; Richard Houlston; Ian Tomlinson; Ioanna Tzoulaki; Jian'an Luan; Jolanda M A Boer; Nita G Forouhi; N Charlotte Onland-Moret; Yvonne T van der Schouw; Renate B Schnabel; Jaroslav A Hubacek; Ruzena Kubinova; Migle Baceviciene; Abdonas Tamosiunas; Andrzej Pajak; Roman Topor-Madry; Sofia Malyutina; Damiano Baldassarre; Bengt Sennblad; Elena Tremoli; Ulf de Faire; Luigi Ferrucci; Stefania Bandenelli; Toshiko Tanaka; James F Meschia; Andrew Singleton; Gerjan Navis; Irene Mateo Leach; Stephan J L Bakker; Ron T Gansevoort; Ian Ford; Stephen E Epstein; Mary Susan Burnett; Joe M Devaney; J Wouter Jukema; Rudi G J Westendorp; Gert Jan de Borst; Yolanda van der Graaf; Pim A de Jong; Anke-Hilse Mailand-van der Zee; Olaf H Klungel; Anthonius de Boer; Pieter A Doevendans; Jeffrey W Stephens; Charles B Eaton; Jennifer G Robinson; JoAnn E Manson; F Gerry Fowkes; Timonthy M Frayling; Jackie F Price; Peter H Whincup; Richard W Morris; Debbie A Lawlor; George Davey Smith; Yoav Ben-Shlomo; Susan Redline; Leslie A Lange; Meena Kumari; Nick J Wareham; W M Monique Verschuren; Emelia J Benjamin; John C Whittaker; Anders Hamsten; Frank Dudbridge; J A Chris Delaney; Andrew Wong; Diana Kuh; Rebecca Hardy; Berta Almoguera Castillo; John J Connolly; Pim van der Harst; Eric J Brunner; Michael G Marmot; Christina L Wassel; Steve E Humphries; Philippa J Talmud; Mika Kivimaki; Folkert W Asselbergs; Mikhail Voevoda; Martin Bobak; Hynek Pikhart; James G Wilson; Hakon Hakonarson; Alex P Reiner; Brendan J Keating; Naveed Sattar; Aroon D Hingorani; Juan Pablo Casas
Journal:  Lancet       Date:  2012-03-14       Impact factor: 79.321

10.  Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.

Authors:  A Kumar; V Thota; L Dee; J Olson; E Uretz; J E Parrillo
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  67 in total

1.  Differential Associations of Chronic Inflammatory Diseases With Incident Heart Failure.

Authors:  Sameer Prasada; Adovich Rivera; Arvind Nishtala; Anna E Pawlowski; Arjun Sinha; Joshua D Bundy; Simran A Chadha; Faraz S Ahmad; Sadiya S Khan; Chad Achenbach; Frank J Palella; Rosalind Ramsey-Goldman; Yvonne C Lee; Jonathan I Silverberg; Babafemi O Taiwo; Sanjiv J Shah; Donald M Lloyd-Jones; Matthew J Feinstein
Journal:  JACC Heart Fail       Date:  2020-04-08       Impact factor: 12.035

2.  Tributyltin stimulates synthesis of interferon gamma and tumor necrosis factor alpha in human lymphocytes.

Authors:  Shanieek Lawrence; Farah Ismail; Sarah Z Jamal; Margaret M Whalen
Journal:  J Appl Toxicol       Date:  2018-03-13       Impact factor: 3.446

Review 3.  NLRP3 Inflammasome: a Novel Insight into Heart Failure.

Authors:  Yunjiao Wang; Yanyang Li; Wanqin Zhang; Zhuo Yuan; Shichao Lv; Junping Zhang
Journal:  J Cardiovasc Transl Res       Date:  2022-06-13       Impact factor: 4.132

4.  [A nomogram based on systemic inflammation markers can predict adverse outcomes in patients with heart failure].

Authors:  Z Liu; X Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-08-20

5.  Effect of aerobic and resistance training on inflammatory markers in heart failure patients: systematic review and meta-analysis.

Authors:  M J Pearson; S F Mungovan; N A Smart
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

6.  Association of the Novel Inflammatory Marker GlycA and Incident Heart Failure and Its Subtypes of Preserved and Reduced Ejection Fraction: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Sunyoung Jang; Oluseye Ogunmoroti; Chiadi E Ndumele; Di Zhao; Vishal N Rao; Oluwaseun E Fashanu; Martin Tibuakuu; James D Otvos; Eve-Marie Benson; Pamela Ouyang; Erin D Michos
Journal:  Circ Heart Fail       Date:  2020-07-28       Impact factor: 8.790

7.  Interleukin-17 aggravates right ventricular remodeling via activating STAT3 under both normoxia and hypoxia.

Authors:  Jing Huang; Wei Zhang; Cai-Lian Zhang; Lei Wang
Journal:  BMC Cardiovasc Disord       Date:  2021-05-21       Impact factor: 2.298

8.  CCL17 Aggravates Myocardial Injury by Suppressing Recruitment of Regulatory T Cells.

Authors:  Guoshuai Feng; Geetika Bajpai; Pan Ma; Andrew Koenig; Andrea Bredemeyer; Inessa Lokshina; Lulu Lai; Irmgard Förster; Florian Leuschner; Daniel Kreisel; Kory J Lavine
Journal:  Circulation       Date:  2022-02-03       Impact factor: 29.690

9.  The health outcomes of inflammation and obesity in patients with heart failure.

Authors:  Zyad T Saleh; Terry A Lennie; Muhammad Darawad; Hamza Alduraidi; Rami A Elshatarat; Issa M Almansour; Debra K Moser
Journal:  Heart Lung       Date:  2020-06-05       Impact factor: 2.210

10.  Sex Differences in the Association Between Inflammation and Event-Free Survival in Patients With Heart Failure.

Authors:  Zyad T Saleh; Ahmad T Alraoush; Ahmad A Aqel; Tagreed O Shawashi; Misook Chung; Terry A Lennie
Journal:  J Cardiovasc Nurs       Date:  2021-07-06       Impact factor: 2.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.